SCHULE; Birgitt

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHULE; Birgitt.The latest application filed is for "crispr knock-out of the alpha-synuclein triplication model of parkinson's disease".

Company Profile

1.8.15

SCHULE; Birgitt - Mountain View CA
SCHULE; Birgitt - Sunnyvale CA
Schule; Birgitt - Menlo Park CA
SCHULE; Birgitt - Portola Valley CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crispr-based Downregulation Of Alpha-synuclein Expression As A Novel Parkinson's Disease Therapeutic App 20210047627 - SCHULE; Birgitt ; et al.	2021-02-18
Crispr Knock-out Of The Alpha-synuclein Triplication Model Of Parkinson's Disease App 20210047623 - SCHULE; Birgitt	2021-02-18
Refining Diagnosis And Treatment Of Complex Multi-symptom Neurological Disorders App 20190085394 - Langston; J. William ; et al.	2019-03-21
Pluripotent cell lines and methods of use thereof Grant 10,233,422 - Reijo Pera , et al.	2019-03-19
Multiple System Atrophy And The Treatment Thereof App 20180179594 - SCHULE; Birgitt	2018-06-28
Site-specific integration of transgenes into human cells Grant 9,932,607 - Calos , et al. April 3, 2	2018-04-03
Pluripotent Cell Lines And Methods Of Use Thereof App 20170114324 - REIJO PERA; Renee Ann ; et al.	2017-04-27
Assay To Determine Lrrk2 Activity In Parkinson's Disease App 20160312194 - NICHOLS; Jeremy ; et al.	2016-10-27
Pluripotent cell lines and methods of use thereof Grant 9,464,273 - Reijo Pera , et al. October 11, 2	2016-10-11
Assay to determine LRRK2 activity in parkinson's disease Grant 9,417,239 - Nichols , et al. August 16, 2	2016-08-16
Screening Assays For Therapeutics For Parkinson's Disease App 20160010154 - LAGANIERE; Josee ; et al.	2016-01-14
Assay To Determine Lrrk2 Activity In Parkinson's Disease App 20160011196 - NICHOLS; Jeremy ; et al.	2016-01-14
Assay to determine LRRK2 activity in parkinson's disease Grant 9,187,567 - Nichols , et al. November 17, 2	2015-11-17
Site-Specific Integration of Transgenes into Human Cells App 20150140665 - Calos; Michele Pamela ; et al.	2015-05-21
COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTION App 20150044193 - Manning-Bog; Amy B. ; et al.	2015-02-12
Compositions And Methods For High-throughput Screening In Skin Fibroblasts With An Alpha-synuclein Triplication App 20150037257 - Mak; Sally ; et al.	2015-02-05
Pluripotent Cell Lines And Methods Of Use Thereof App 20140356455 - Reijo Pera; Renee Ann ; et al.	2014-12-04
Pluripotent cell lines and methods of use thereof Grant 8,669,048 - Reijo Pera , et al. March 11, 2	2014-03-11
Zinc Finger Nuclease Modification Of Leucine Rich Repeat Kinase 2 (lrrk2) Mutant Fibroblasts And Ipscs App 20120214241 - LAGANIERE; Josee ; et al.	2012-08-23
Pluripotent cell lines and methods of use thereof App 20100167286 - Reijo Pera; Renee Ann ; et al.	2010-07-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.